Actelion to host Conference Call/ Audiocast on BUILD-3 Study Results at 15.30 hrs Swiss time

Actelion to host Conference Call/ Audiocast on BUILD-3 Study Results at 15.30 hrs Swiss time

ID: 12995

(Thomson Reuters ONE) -
Actelion Pharmaceuticals Ltd / Actelion to host Conference Call/ Audiocast on BUILD-3 Study Results at 15.30 hrs Swiss time processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.

Dear member of the investment community



Actelion Ltd will host a Conference Call/ Audiocast on BUILD-3 Study Results
today, on Monday, 01 March 2010, at 15.30 CET / 14.30 GMT/ 09.30 EST





Date/Time:




01 March 2010 15.30 hrs - 16.30 hrs Basel (CET)

  14.30 hrs - 15.30 hrs UK (GMT)

  09.30 a.m. - 10.30 a.m. US (EST)




Conference Call Connect #:

Dial-in participants should start calling the number below 10-15 minutes before
the conference is due to start.




Dial: Europe: +41 (0)44 580 73 89

  UK: +44 (0)203 147 47 53

  US: +1 866 931 15 72





Participant's mode:

Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their Name and Company.


Audiocast Access:

Audiocast participants should visit the Actelion website
http://www.actelion.com/en/investors/events/investor-audiocast.page? for further
details
10-15 minutes before the conference is due to start.

If you experience any access problems go directly to the URL:
http://gaia.world-television.com/actelion/20100301/trunc





Participant's mode:

Listen only



Audiocast Replay:

The archived Investor Audiocast will be available for replay through
http://www.actelion.com approximately 60 minutes after the call has ended.



For further information please contact:





Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH-4123 Allschwil

Roland Haefeli

Vice President, Head of Investor Relations & Public
Affairs

+41 61 565 62 62

+1 646 737 49 72

http://www.actelion.com





[HUG#1389344]



--- End of Message ---

Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland

WKN: 936767;ISIN: CH0010532478;

Webcast: http://gaia.world-television.com/actelion/20100301/trunc
Press Release PDF: http://hugin.info/131801/R/1389344/347549.pdf




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Paid content on the rise: The SPIEGEL iPhone App is purchasable via ClickandBuy Northland Appoints Banks for Project Financing
Bereitgestellt von Benutzer: hugin
Datum: 01.03.2010 - 07:10 Uhr
Sprache: Deutsch
News-ID 12995
Anzahl Zeichen: 0

contact information:
Town:

Allschwil



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 249 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Actelion to host Conference Call/ Audiocast on BUILD-3 Study Results at 15.30 hrs Swiss time"
steht unter der journalistisch-redaktionellen Verantwortung von

Actelion Pharmaceuticals Ltd (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Actelion Pharmaceuticals Ltd



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z